Literature DB >> 26516010

Association of APOC3 Loss-of-Function Mutations With Plasma Lipids and Subclinical Atherosclerosis: The Multi-Ethnic BioImage Study.

Pradeep Natarajan, Puja Kohli, Usman Baber, Khanh-Dung H Nguyen, Samantha Sartori, Dermot F Reilly, Roxana Mehran, Pieter Muntendam, Valentin Fuster, Daniel J Rader, Sekar Kathiresan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26516010      PMCID： PMC4706229          DOI： 10.1016/j.jacc.2015.08.866

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  5 in total

1.  Prevalence, impact, and predictive value of detecting subclinical coronary and carotid atherosclerosis in asymptomatic adults: the BioImage study.

Authors:  Usman Baber; Roxana Mehran; Samantha Sartori; Mikkel Malby Schoos; Henrik Sillesen; Pieter Muntendam; Mario J Garcia; John Gregson; Stuart Pocock; Erling Falk; Valentin Fuster
Journal:  J Am Coll Cardiol       Date:  2015-03-24       Impact factor: 24.094

2.  A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection.

Authors:  Toni I Pollin; Coleen M Damcott; Haiqing Shen; Sandra H Ott; John Shelton; Richard B Horenstein; Wendy Post; John C McLenithan; Lawrence F Bielak; Patricia A Peyser; Braxton D Mitchell; Michael Miller; Jeffrey R O'Connell; Alan R Shuldiner
Journal:  Science       Date:  2008-12-12       Impact factor: 47.728

3.  Loss-of-function mutations in APOC3, triglycerides, and coronary disease.

Authors:  Jacy Crosby; Gina M Peloso; Paul L Auer; David R Crosslin; Nathan O Stitziel; Leslie A Lange; Yingchang Lu; Zheng-zheng Tang; He Zhang; George Hindy; Nicholas Masca; Kathleen Stirrups; Stavroula Kanoni; Ron Do; Goo Jun; Youna Hu; Hyun Min Kang; Chenyi Xue; Anuj Goel; Martin Farrall; Stefano Duga; Pier Angelica Merlini; Rosanna Asselta; Domenico Girelli; Oliviero Olivieri; Nicola Martinelli; Wu Yin; Dermot Reilly; Elizabeth Speliotes; Caroline S Fox; Kristian Hveem; Oddgeir L Holmen; Majid Nikpay; Deborah N Farlow; Themistocles L Assimes; Nora Franceschini; Jennifer Robinson; Kari E North; Lisa W Martin; Mark DePristo; Namrata Gupta; Stefan A Escher; Jan-Håkan Jansson; Natalie Van Zuydam; Colin N A Palmer; Nicholas Wareham; Werner Koch; Thomas Meitinger; Annette Peters; Wolfgang Lieb; Raimund Erbel; Inke R Konig; Jochen Kruppa; Franziska Degenhardt; Omri Gottesman; Erwin P Bottinger; Christopher J O'Donnell; Bruce M Psaty; Christie M Ballantyne; Goncalo Abecasis; Jose M Ordovas; Olle Melander; Hugh Watkins; Marju Orho-Melander; Diego Ardissino; Ruth J F Loos; Ruth McPherson; Cristen J Willer; Jeanette Erdmann; Alistair S Hall; Nilesh J Samani; Panos Deloukas; Heribert Schunkert; James G Wilson; Charles Kooperberg; Stephen S Rich; Russell P Tracy; Dan-Yu Lin; David Altshuler; Stacey Gabriel; Deborah A Nickerson; Gail P Jarvik; L Adrienne Cupples; Alex P Reiner; Eric Boerwinkle; Sekar Kathiresan
Journal:  N Engl J Med       Date:  2014-06-18       Impact factor: 91.245

4.  Loss-of-function mutations in APOC3 and risk of ischemic vascular disease.

Authors:  Anders Berg Jørgensen; Ruth Frikke-Schmidt; Børge G Nordestgaard; Anne Tybjærg-Hansen
Journal:  N Engl J Med       Date:  2014-06-18       Impact factor: 91.245

5.  Association of low-frequency and rare coding-sequence variants with blood lipids and coronary heart disease in 56,000 whites and blacks.

Authors:  Gina M Peloso; Paul L Auer; Joshua C Bis; Arend Voorman; Alanna C Morrison; Nathan O Stitziel; Jennifer A Brody; Sumeet A Khetarpal; Jacy R Crosby; Myriam Fornage; Aaron Isaacs; Johanna Jakobsdottir; Mary F Feitosa; Gail Davies; Jennifer E Huffman; Ani Manichaikul; Brian Davis; Kurt Lohman; Aron Y Joon; Albert V Smith; Megan L Grove; Paolo Zanoni; Valeska Redon; Serkalem Demissie; Kim Lawson; Ulrike Peters; Christopher Carlson; Rebecca D Jackson; Kelli K Ryckman; Rachel H Mackey; Jennifer G Robinson; David S Siscovick; Pamela J Schreiner; Josyf C Mychaleckyj; James S Pankow; Albert Hofman; Andre G Uitterlinden; Tamara B Harris; Kent D Taylor; Jeanette M Stafford; Lindsay M Reynolds; Riccardo E Marioni; Abbas Dehghan; Oscar H Franco; Aniruddh P Patel; Yingchang Lu; George Hindy; Omri Gottesman; Erwin P Bottinger; Olle Melander; Marju Orho-Melander; Ruth J F Loos; Stefano Duga; Piera Angelica Merlini; Martin Farrall; Anuj Goel; Rosanna Asselta; Domenico Girelli; Nicola Martinelli; Svati H Shah; William E Kraus; Mingyao Li; Daniel J Rader; Muredach P Reilly; Ruth McPherson; Hugh Watkins; Diego Ardissino; Qunyuan Zhang; Judy Wang; Michael Y Tsai; Herman A Taylor; Adolfo Correa; Michael E Griswold; Leslie A Lange; John M Starr; Igor Rudan; Gudny Eiriksdottir; Lenore J Launer; Jose M Ordovas; Daniel Levy; Y-D Ida Chen; Alexander P Reiner; Caroline Hayward; Ozren Polasek; Ian J Deary; Ingrid B Borecki; Yongmei Liu; Vilmundur Gudnason; James G Wilson; Cornelia M van Duijn; Charles Kooperberg; Stephen S Rich; Bruce M Psaty; Jerome I Rotter; Christopher J O'Donnell; Kenneth Rice; Eric Boerwinkle; Sekar Kathiresan; L Adrienne Cupples
Journal:  Am J Hum Genet       Date:  2014-02-06       Impact factor: 11.025
  5 in total
  15 in total

Review 1.  Emerging strategies of targeting lipoprotein lipase for metabolic and cardiovascular diseases.

Authors:  Werner J Geldenhuys; Li Lin; Altaf S Darvesh; Prabodh Sadana
Journal:  Drug Discov Today       Date:  2016-10-19       Impact factor: 7.851

2.  Identity-by-Descent Mapping Identifies Major Locus for Serum Triglycerides in Amerindians Largely Explained by an APOC3 Founder Mutation.

Authors:  Wen-Chi Hsueh; Anup K Nair; Sayuko Kobes; Peng Chen; Harald H H Göring; Toni I Pollin; Alka Malhotra; William C Knowler; Leslie J Baier; Robert L Hanson
Journal:  Circ Cardiovasc Genet       Date:  2017-12

Review 3.  Insights from population-based analyses of plasma lipids across the allele frequency spectrum.

Authors:  Gina M Peloso; Pradeep Natarajan
Journal:  Curr Opin Genet Dev       Date:  2018-02-13       Impact factor: 5.578

Review 4.  The Remnant Lipoprotein Hypothesis of Diabetes-Associated Cardiovascular Disease.

Authors:  Karin E Bornfeldt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2022-05-26       Impact factor: 10.514

Review 5.  GPIHBP1 and Plasma Triglyceride Metabolism.

Authors:  Loren G Fong; Stephen G Young; Anne P Beigneux; André Bensadoun; Monika Oberer; Haibo Jiang; Michael Ploug
Journal:  Trends Endocrinol Metab       Date:  2016-05-14       Impact factor: 12.015

6.  Relationship of lipoprotein-associated apolipoprotein C-III with lipid variables and coronary artery disease risk: The EPIC-Norfolk prospective population study.

Authors:  Julian C van Capelleveen; Sang-Rok Lee; Rutger Verbeek; John J P Kastelein; Nicholas J Wareham; Erik S G Stroes; G Kees Hovingh; Kay-Tee Khaw; S Matthijs Boekholdt; Joseph L Witztum; Sotirios Tsimikas
Journal:  J Clin Lipidol       Date:  2018-08-29       Impact factor: 4.766

7.  Very-Low-Density Lipoprotein-Associated Apolipoproteins Predict Cardiovascular Events and Are Lowered by Inhibition of APOC-III.

Authors:  Raimund Pechlaner; Sotirios Tsimikas; Xiaoke Yin; Peter Willeit; Ferheen Baig; Peter Santer; Friedrich Oberhollenzer; Georg Egger; Joseph L Witztum; Veronica J Alexander; Johann Willeit; Stefan Kiechl; Manuel Mayr
Journal:  J Am Coll Cardiol       Date:  2017-02-21       Impact factor: 24.094

8.  Polygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention Setting.

Authors:  Pradeep Natarajan; Robin Young; Nathan O Stitziel; Sandosh Padmanabhan; Usman Baber; Roxana Mehran; Samantha Sartori; Valentin Fuster; Dermot F Reilly; Adam Butterworth; Daniel J Rader; Ian Ford; Naveed Sattar; Sekar Kathiresan
Journal:  Circulation       Date:  2017-02-21       Impact factor: 29.690

Review 9.  Triglyceride-Rich Lipoproteins and Remnants: Targets for Therapy?

Authors:  Geesje M Dallinga-Thie; Jeffrey Kroon; Jan Borén; M John Chapman
Journal:  Curr Cardiol Rep       Date:  2016-07       Impact factor: 2.931

Review 10.  Why Is Apolipoprotein CIII Emerging as a Novel Therapeutic Target to Reduce the Burden of Cardiovascular Disease?

Authors:  Marja-Riitta Taskinen; Jan Borén
Journal:  Curr Atheroscler Rep       Date:  2016-10       Impact factor: 5.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.